Joan Connolly joined Albireo in April 2021 as Chief Technology Officer with extensive experience in biopharma commercial leadership including manufacturing management, product commercialization and supply chain management. Prior to joining Albireo, Joan was the Senior Vice President of Technical Operations at Stemline Therapeutics where she led their product, ELZONRIS® (tagraxofusp-erzs), from Investigational New Drug (IND) stage through commercialization. Earlier in her career, Joan held senior roles at ImClone Systems and Bristol-Myers Squibb. She holds a bachelor’s degree in chemical engineering from Queen’s University.